The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PAOLA-1: An ENGOT/GCIG phase III trial of olaparib versus placebo combined with bevacizumab as maintenance treatment in patients with advanced ovarian cancer following first-line platinum-based chemotherapy plus bevacizumab.
 
Isabelle Ray-Coquard
No Relationships to Disclose
 
Frédéric Selle
No Relationships to Disclose
 
Philipp Harter
No Relationships to Disclose
 
Claire Cropet
No Relationships to Disclose
 
Christian Marth
No Relationships to Disclose
 
Ignace Vergote
No Relationships to Disclose
 
Keiichi Fujiwara
No Relationships to Disclose
 
Antonio Gonzalez-Martin
No Relationships to Disclose
 
Sandro Pignata
No Relationships to Disclose
 
Nicoletta Colombo
No Relationships to Disclose
 
Johanna Unelma Maenpaa
No Relationships to Disclose
 
Eric Pujade-Lauraine
No Relationships to Disclose